Adjuvant (BMS CA224098 Relativity)
- Result Type
- clinical trial
A Study to Assess Adjuvant Immunotherapy With Relatlimab and Nivolumab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma (RELATIVITY-098)
Status: Active, Recruiting
Currently displaying10Showing results
- Results per page
- Currently displaying10Results per page
- Display30Results per page
- Display50Results per page
13results found for:
Adjuvant Merkel Cell (ECOG-ACRIN EA6174)
- Result Type
- clinical trial
Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer
Status: Active, Recruiting
City of Hope 96144 Molecular Genetics Studies of Cancer Patients and Their Relatives
- Result Type
- clinical trial
The purpose of this study is to find out how genetics, biologics and behavior might contribute to
Status: Active, Recruiting
Locally Advanced or Metastatic (ASTX029)
- Result Type
- clinical trial
Study of ASTX029 in Subjects With Advanced Solid Tumors
Status: Active, Recruiting
Locally Advanced or Metastatic (Genentech GO42273 NRAS)
- Result Type
- clinical trial
A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Atezolizumab in Pat
Status: Active, Recruiting
Metastatic (CPMC19-MEL01)
- Result Type
- clinical trial
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation
Status: Active, Recruiting
Metastatic (ECOG-ACRIN EA6141)
- Result Type
- clinical trial
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
Status: Active, Recruiting
Metastatic (Ideaya Biosciences IDE196-001)
- Result Type
- clinical trial
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Status: Active, Recruiting
Metastatic (SBRT and Immunotherapy IIP Minor) Temporary Enrollment Hold
- Result Type
- clinical trial
A PHASE II STUDY OF CONCURRENT STEREOTACTIC BODY RADIOTHERAPY WITH RELATLIMAB AND NIVOLUMAB IN PATIENTS WITH METASTATIC UVEAL MELANOMA
Metastatic (Tesaro IIP Kim)
- Result Type
- clinical trial
Phase II study of niraparib in patients with advanced melanoma with genetic homologous recombination (HR) mutation / alteration
Status: Active, Recruiting
Currently displaying10Showing results
- Results per page
- Currently displaying10Results per page
- Display30Results per page
- Display50Results per page